Single carcinoma cells at the deepest invasive portion correlate with metastatic potential of advanced colorectal carcinoma

International Journal of Oncology

Volumn 10, Issue 6, 1997, Pages 1141-1145

  Hiraga, Yuko ^a   Tanaka, Shinji ^a   Haruma, Ken ^a   Yoshihara, Masaharu ^a   Sumii, Koji ^a   Kajiyama, Goro ^a   Shimamoto, Fumio ^b  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

colorectal carcinoma; cytokeratin; metastasis; prognosis; single carcinoma cell

Indexed keywords

CYTOKERATIN;

ADULT; AGED; ANIMAL TISSUE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER INVASION; CANCER SURGERY; CARCINOMA CELL; CELL DIFFERENTIATION; CLINICAL FEATURE; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROGNOSIS;

EID: 0030962447     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.10.6.1141     Document Type: Article

References (14)

1. Teixeira CR, Tanaka S, Haruma K, Yoshihara M, Sumii K, Kajiyama G and Shimamoto F: The clinical significance of the histologic subclassification of colorectal carcinoma. Oncology 50: 495-499, 1993.
2. Tanaka S, Haruma K, Tatsuta S, Hiraga Y, Teixeira CR, Shimamoto F, Yoshihara M, Sumii K and Kajiyama G: Proliferating cell nuclear antigen expression correlates with the metastatic potential of submucosal invasive colorectal carcinoma. Oncology 52: 134-139, 1995.
3. Teixeira CR, Tanaka S, Haruma K, Yoshihara M, Sumii K and Kajiyama G: Proliferating cell nuclear antigen expression at the invasive tumor margin predicts malignant potential of colorectal carcinomas. Cancer 73: 575-579, 1994.
4. Tanaka S, Haruma K, Teixeira CR, Tatsuta S, Ohtsu N, Hiraga Y, Yoshihara M, Sumii K, Kajiyama G and Shimamoto F: Endoscopic treatment of submucosal invasive colorectal carcinoma with special reference to risk factors for lymph node metastasis. J Gastroenterol 30: 710-717, 1995.
5. Tanaka S, Haruma K, Hiraga Y, Okamoto T, Kimura T, Koike N, Tanimoto T, Kunihiro M, Goishi H, Yoshihara M, Sumii K, Kajiyama G and Shimamoto F: Histologic subclassification of 'moderately differentiated adenocarcinoma' - clinical significance of the histologic subclassification at the deepest site of invasion of colorectal cancer. Endoscopia Digestiva (in Japanese with English abstract) 8: 923-929, 1996.
6. Jass JR and Sobin LH: Histological typing of intestinal tumours. In: International Histological Classification of Tumours. 2nd edition. WHO (eds). Springer, Berlin pp29-40, 1989.
7. Japanese Research Society for Cancer of Colon and Rectum: General rules for clinical and pathological studies on cancer of the colon, rectum and anus. 5th edition. Kanahara, Tokyo, 1994.
8. Fujisaki J and Shimoda T: Expression of cytokeratin subtypes in colorectal mucosa, adenoma, and carcinoma. Gastroenterol Jpn 28: 647-656, 1993.
9. Schlimok G, Funke I, Bock B, Schweiberer B, Witte J and Riethmüller G: Epithelial tumor cells in bone marrow of patients with colorectal cancer: immunocytochemical detection, phenotypic characterization, and prognostic significance. J Clin Oncol 8: 831-837, 1990.
10. Lindemann F, Schlimok G, Dirschedl P, Witte J and Riethmüller G: Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet 340: 685-689, 1992.
11. Haboubi NY, Clark P, Kaftan SM and Schofield PF: The importance of combining xylene clearance and immunohisto-chemistry in the accurate staging of colorectal carcinoma. J R Soc Med 85: 386-388, 1992.
12. Cutait R, Alves VAF, Lopes LC, Cutait DE, Borges JLA, Singer J, Da Suva JH and Goffi FS: Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins. Dis Colon Rectum 34: 917-920, 1991.
13. Greenson JK, Isenhart CE, Rice R, Mojzisik C, Houchens D and Martin EW Jr: Identification of occult micrometastases in pericolic lymph nodes of Dukes' B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49; correlation with long-term survival. Cancer 73: 563-569, 1994.
14. Sinicrope FA, Hart J, Brasitus TA, Michelassi F, Lee JJ and Safa AR: Relationship of P-glycoprotein and carcinoembryonic antigen expression in human colon carcinoma to local invasion, DMA ploidy, and disease relapse. Cancer 74: 2908-2917, 1994.